Germany· DE-A57-0119cec815a11009
Atosiban Ever Pharma
A atosiban product containing atosiban, registered in Germany by Ever Valinject Gmbh. The same ATC class is registered in 14 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Atosiban is registered in 14 of 19 countries.
Countries holding a registration under ATC G02CX01 (atosiban), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Atosiban · ATC G02CX01
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Atosiban
- Manufacturer
- Ever Valinject Gmbh
- Country
- Germany (DE)
- ATC code
- G02CX01
- ATC class
- Atosiban
- Defined daily dose
- 165 mg, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Atosiban in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainATOSIBAN ACCORD 37,5 MG/5 ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- United KingdomAtosiban 37.5mg/5ml concentrate for solution for infusion vialsSun Pharma UK Ltd
- FranceATOSIBAN ACCORD 37,5 mg/5 ml, solution à diluer pour perfusionACCORD HEALTHCARE FRANCE
- FinlandAtosiban AccordAccord Healthcare B.V.
- BelgiumAtosiban Altan 37.5 mg/5 mlAltan Pharma
- PolandAtosiban AccordAccord Healthcare Polska Sp. z o.o.
- SwedenAtosiban Accord 37,5 mg/5 ml Koncentrat till infusionsvätska, lösningAccord Healthcare B.V.
- NetherlandsAtosiban Accord 37,5 mg/5 ml concentraat voor oplossing voor infusieAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Atosiban Altan, Atosiban Ever Pharma
- Belgium · Atosiban Ever Pharma
- Bulgaria · Атозибан Ever Pharma
- Czechia · Atosiban Avmc, Atosiban Ever Pharma
- Denmark · Atosiban Ever Pharma
- Spain · Atosiban Altan Pharmaceuticals, S.A., Atosiban Ever Pharma
- Finland · Atosiban Ever Pharma
- France · Atosiban Altan, Atosiban Altan Pharmaceuticals, S.A.
- United Kingdom (Northern Ireland) · Atosiban Ibigen
- Greece · Atosiban Ever Pharma
- Croatia · Atosiban Ever Pharma, Atosiban Makpharm
- Iceland · Atosiban Sun, Tractocile
- Italy · Atosiban Ever Pharma, Atosiban Ibisqus
- Liechtenstein · Tractocile
- Luxembourg · Atosiban Ever Pharma
- Latvia · Atosiban Pharmidea
- Netherlands · Atosiban Accord, Atosiban Ever Pharma
- Norway · Atosiban Ever Pharma, Atosiban Sun
- Poland · Atosiban Ever Pharma
- Portugal · Atosiban Ever Pharma, Atosibano Altan
- Sweden · Atosiban Accord, Atosiban Ever Pharma
- Slovenia · Atoziban Ever Pharma
- Slovakia · Atosiban Ardez
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0ba38a29-55f4-4cdd-aa0d-f88a0ec1b5e5 GET /v1/drugs/0ba38a29-55f4-4cdd-aa0d-f88a0ec1b5e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Atosiban",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about atosiban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.